contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


obducat-receives-order-for-nil-system-from-a-european-institute

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Obducat is a global supplier of lithography solutions within nanoimprint, surface coating and wet processing technology. The company develops and delivers technology, products, processes and production services for the fabrication and replication of advanced micro- and nanostructures. Obducat's products and services are used in LED, display, optics, photonics, MEMS and sensor industries as well as in power and high-frequency electronics. Obducat was founded in 1989 and is headquartered in Lund.

Obducat

OBDUCAT has received an order for an EITRE 3 nanoimprint lithography (NIL) system. The order value amounts to approximately SEK 2.1 million and delivery is planned for the second quarter of ...

<div class="mfn-preamble"><p><strong>OBDUCAT has received an order for an EITRE 3 nanoimprint lithography (NIL) system. The order value amounts to approximately SEK 2.1 million and delivery is planned for the second quarter of 2026.</strong></p></div><div class="mfn-body"><p>The institute will use the EITRE 3 system for research and development of next-generation technologies in areas such as advanced computing and medical applications. The development of these technologies relies on extremely small and precise structures, and the EITRE 3 system provides the customer with the advanced manufacturing capabilities required to develop and test such solutions using both thermal and UV-based nanoimprint lithography.</p></div><div class="mfn-footer mfn-contacts mfn-8a53138b0c01"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Henri Bergstrand, Chairman: +46 (0)46-10 16 00 or +46 (0) 708-88 72 45<br>Patrik Lundström, CEO: +46 (0)46 10 16 00 or +46 (0) 703 27 37 38</p><hr></div><div class="mfn-footer mfn-about mfn-de16b03f9a03"><p><strong class="mfn-heading-1">About Obducat AB (publ)</strong><br>Obducat AB (publ) is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro and nano structures. Obducat's products and services serve the demands of customers worldwide within the LED and Display, Optics and Photonics, MEMS and Sensor industries as well as in High Power and High Frequency electronics and Biomedical Devices. Obducat's technologies include nano imprint technology, resist- and wet processing technologies. Obducat has its own market presence in Sweden, Germany, Japan, USA, England, Portugal and China and the headquarter is located in Lund, Sweden. Obducat is a public company. The Obducat share is traded on the Swedish NGM Main Regulated Equity exchange. Read more at <a href="http://www.obducat.com" rel="noopener">www.obducat.com</a> or contact us via email <a href="mailto:investorrelations@obducat.com" rel="noopener">investorrelations@obducat.com</a></p><hr></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a class="mfn-generated mfn-primary" href="https://storage.mfn.se/c3ecda12-2eb5-495c-90ef-7662e4748d2c/obducat-receives-order-for-nil-system-from-a-european-institute.pdf" rel="noopener">Obducat receives order for NIL system from a European Institute</a></p></div>

Obducat receives order for NIL system from a European Institute

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Nordea Bank

Aktionær i Nordea? Det er nemmere end nogensinde at deltage i Nordeas generalforsamling takket være nyt digitalt setup

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation